Today ARGS ranks # as SELL CANDIDATE.
Today ARGS ranks # as SELL CANDIDATE.

ARGS stock Argos Therapeutics

ARGS stock
Argos Therapeutics

April 25, 2019
Change 0.00%
Chart period: 2019-01-28 - 2019-04-25





Will ARGS stock price go up or down on Fri, 26 Apr 2019?

Argos Therapeutics Forecast and Stock Analysis

Technical ARGS stock analysis for April 25, 2019.

Sell candidate since 2019-04-16
Shorts 0.94% ( 2018-03-29 )
Cash n/a
Loans n/a
Beta 1.66
ROA -61.64

No changes to the price of Argos Therapeutics in the last trading day. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

Close price at the end of the last trading day (Thursday, 25th Apr 2019) of the ARGS stock was $0.08.

During day the stock fluctuated 29.03% from a day low at $0.06 to a day high of $0.08.

30 day high of the ARGS stock price was $0.09 and low was $0.06.
90 day high was $0.09 and low was $0.05.
52 week high for the Argos Therapeutics - $0.29 and low - $0.02.


Argos Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.26% during the next 3 months and, with 90% probability hold a price between $0.07 and $0.11 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Monday April 08, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Argos Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.08 and $0.08. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 33 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $0.07 and $0.07.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Argos Therapeutics finds support just below today's level at $0.07. If this is broken, then the next support from accumulated volume will be at $0.07 and $0.06.

Support: $0.07 Price: $0.08 Resistance: $0.08


In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Today ARGS ranks # as SELL CANDIDATE.
Today ARGS ranks # as SELL CANDIDATE.